Actual Medicinal Product (AMP) - Relvar Ellipta 184micrograms/dose / 22micrograms/dose dry powder inhaler (GlaxoSmithKline UK Ltd)

Navigation

Name Details

Name Start Date End Date
Name Current Name Relvar Ellipta 184micrograms/dose / 22micrograms/dose dry powder inhaler Start Date 18-02-2014 End Date
Previous Name Previous Name Relvar Ellipta 184micrograms/dose / 22micrograms/dose inhaler Start Date 12-12-2013 End Date 17-02-2014
Abbreviated Name Abbreviated Name Relvar Ellipta 184microg/dose / 22microg/dose dry pdr inh Start Date 18-02-2014
Previous Abbreviated Name Relvar Ellipta 184microg/dose / 22microg/dose inhaler Previous Start Date 12-12-2013 Previous End Date 17-02-2014

Summary

Licensed Route
Inhalation
Availability Restrictions
None
Licensing Authority
Medicines - MHRA/EMA
EMA Indicator

Codes

BNF Start Date End Date
Previous BNF 03020000 Start Date 25-06-2014 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
23621711000001102 12-12-2013

Parent Products

Actual Medicinal Product Pack (AMPP) Information

Pack Size Indicative Price Discontinued
30 dose 2950